3Agostino P, Mareczi G, Lquri G, et al. Sustained improvement in unctional capacity after removal of body fluid with i~late ultrafil-tration in chronic cardiac insufficiency. Am J Med, 1994,96:191.
4De vriese AS, Colardyn FA, Phillppe JJ, et al. Cytokine removal uring continuous hemofiltration in septic paatients. J Am SOc ephorl. 1999,10: 846.
5Schetz MRC. Classical and alternative indication for continuousrenal replacement therapy. Kidney Int, 1998,53 ( Suppl 66): 129.
6Tetta C, Mariano F, Ronco C, et al. Relevance of platele-activating factor in inflammation and sepsis: mechnisms and kidney removal inextracorporeal treatment. Am J Kidney Dis, 1997, 30 ( 5Suppl 4 ):S57.
7Ronco C, Bellomo R. Continuous renal replacment therapy: Evolution in techololgy and current nomenclature. Kidney Int. 1998,53 (Suppl66):160.
8Van Bommel EFH. Bouvy ND,So KL, et al. Acute dialytic support for the critically ill: Intermittent hemodialysis versus continuous arte-riovenous hemodiafiltration. Am J Nephrol, 1995,15: 192.
9Cosentino F, Paganini E, Lockrem J, et al. Continuous arteriove-nous hemofiltration in the adult respiratory distress syndrome. Con-trib Nephrol, 1991,93:94.
10Sivak ED,Tita J , Meden G, et al. Effects of furosernide versus iso-lated ultrafiltration on extravascular lung water in oleic acid-induced ulmonary edema. Crit Care Med, 1986,14:48.
